Tuberculous meningoencephalitis in HIV-seronegative patients: variety of clinical presentation and impact on diagnostics and treatment

Acta Neurologica Scandinavica
J KassubekT Els

Abstract

Tuberculous meningoencephalitis (TBM), an infrequent disease in Western European countries, shows a wide heterogeneity of clinical symptoms. We present 4 patients (age range 42-72 years) with the definite diagnosis of isolated TBM. All patients were HIV-seronegative, only 1 patient was known to be immunoincompetent on admission due to acute myelocytic leukemia; other reasons for immune suppression were detected in 2 other patients (leukemia and idiopathic CD4+ T-lymphocytopenia, respectively). The diagnosis of TBM was confirmed in 3 cases by culture from CSF, in 1 case Mycobacterium tuberculosis was proven only in tracheal aspirate. In 1 patient M. bovis was found, which is an extremely rare cause of TBM in Germany. We report the contributions of different diagnostic tools (CSF analysis, neuroimaging) in reaching the presumptive diagnosis and in monitoring the further course. All patients developed neurological complications despite prompt tuberculostatic treatment. Three of the patients presented a chronic severe loss of consciousness of unclear origin. The possible causative relationships of these complications and their impact on the prognosis are discussed.

References

Jan 1, 1986·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·D K Dastur
Nov 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M Salfinger, G E Pfyffer
Dec 1, 1994·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·P de March-Ayuela
Aug 1, 1996·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·P SethM Chakraborty
Apr 1, 1996·Journal of Tropical Pediatrics·A K PatwariS K Arora
Sep 22, 1998·Electroencephalography and Clinical Neurophysiology·J Kalita, U K Misra
Feb 20, 1999·QJM : Monthly Journal of the Association of Physicians·A S KarstaedtH H Crewe-Brown
Jan 29, 2000·International Journal of Dermatology·M MatsuiS Imamura
Feb 16, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·G ThwaitesJ Farrar
Sep 6, 2000·British Journal of Haematology·S SignoriniL Imberti

❮ Previous
Next ❯

Citations

Jan 11, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Jaime L TartarAllan J Nash
Aug 19, 2016·Neurology·Anusha van SamkarDiederik van de Beek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
Jaime L TartarAllan J Nash
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Claudio BabiloniAlfredo Pennica
© 2022 Meta ULC. All rights reserved